期刊文献+

Toll样受体-4表达对树突状细胞表型及功能的影响 被引量:1

Effect of TLR-4 on phenotypes and function of dendritic cells
原文传递
导出
摘要 目的:探讨Toll样受体-4(TLR-4)表达对树突状细胞(DC)表型及功能的影响及其机制。方法:以构建的含有TLR-4全基因序列的pc DNA3.1质粒载体为模板,通过m MESSAGE m MACHINE T7 Kit体外转录获得TLR-4 m RNA,并采用脂质体法将其转染健康人外周血PBMC来源的DC,用流式细胞术检测鉴定转染后DC表面功能性分子的表达及DC体外诱导细胞毒性T淋巴细胞(CTL)分泌细胞因子的能力。结果:成功构建人TLR-4-pc DNA3.1质粒载体;体外扩增成功人TLR-4和EGFP m RNA片段。TLR-4 m RNA转染后的DC表面趋化因子CCR7及功能性分子HLA-DR的表达显著高于control m RNA转染DC、转染前成熟DC[CCR-7:(42.4±4.93)%vs(20.1±3.09)%、(17.1±4.33)%,P<0.05;HLA-DR:(62.1±7.23)%vs(17.7±6.01)%、(25.8±4.16)%,P<0.05],同时转染后的DC体外诱导CTL分泌IFN-γ细胞因子的能力强于control m RNA-DC、空载转染DC诱导的CTL及加入DC前CTL[(66.5±3.58)%vs(41.1±4.27)%、(37.9±2.96)%、(3.2±2.03)%,P<0.05]。结论:TLR-4 m RNA转染DC可显著增强DC的功能,提高了DC抗原提呈及诱导CTL的能力,为增强DC疫苗抗肿瘤效应提供实验依据。 Objective:To investigate whether the expression of Toll like receptor-4(TLR-4) has an effect on the phenotypes and function of dendritic cells(DCs) and the possible mechanism.Methods:pc DNA3.1 plasmid encoding full TLR-4 gene sequence was constructed as a template to obtain TLR-4 m RNA through in vitro transcription using m MESSAGE m MACHINE T7 Kit;DCs from healthy human peripheral blood were transfected with TLR-4m RNA by liposomal transfection.The functional molecule expression on DC surface and the ability of DC inducing cytotoxic T lymphocytes(CTLs) to secrete cytokines in vitro were detected by Flow cytometry after transfection.Results:Human TLR-4-pc DNA3.1 plasmid was successfully constructed;human TLR-4 and EGFP m RNA fragments were successfully amplified.The Flow cytometry results showed that the expressions of chemokine CCR7 and functional molecule HLA-DR on dendritic cell surface were significantly increased after transfection with TLR-4 m RNA compared with control m RNA transfection or pre-transfection(CCR7:[42.4 ± 4.93]% vs [20.1 ± 3.09]%,[17.1±4.33]%,P〈0.05;HLA-DR:[62.1±7.23]% vs [17.7±6.01]%,[25.8±4.16]%,P〈0.05);and the ability of secreting IFN-γ from CTLs induced by TLR-4 m RNA-DCS was significantly enhanced in vitro compared with control m RNA-DC,empty-DC and PBMC([66.5±3.58]% vs [41.1±4.27]%,[37.9±2.96]%,[3.2±2.03]%,P〈0.05).Conclusion:The function of dendritic cells could be significantly enhanced by TLR-4 m RNA transfection.The ability of antigen presentation and inducing CTLs of dendritic cell were improved,which would provide an experimental basis for enhancing the anti-tumor effect of DC vaccines.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2017年第9期950-954,共5页 Chinese Journal of Cancer Biotherapy
基金 国家临床重点专科建设项目资助 福建省科技计划项目资助(No.2017Y0022) 福建省自然基金项目资助(No.2016J01514)~~
关键词 树突状细胞 细胞毒性T淋巴细胞 TOLL样受体-4 抗原提呈 免疫应答 dendritic cell cytotoxic T lymphocyte(CTL) Toll-like receptor-4(TLR4) antigen presenting immune response
  • 相关文献

参考文献10

二级参考文献323

  • 1谢志强,吕斌,邹立君,尚学兰,周宜开.湖北人群Toll样受体4基因多态性研究[J].华中科技大学学报(医学版),2004,33(5):630-632. 被引量:11
  • 2于哲,马保安,周勇,张明华,张云飞,范清宇.异体树突状细胞融合瘤苗抗骨肉瘤的免疫效应实验[J].肿瘤防治研究,2006,33(11):779-783. 被引量:6
  • 3邓旻,窦晓兵,史亦谦,沃兴德.黄芪多糖定向诱生脐血来源树突状细胞及其对T细胞增殖作用的研究[J].中国免疫学杂志,2007,23(6):539-544. 被引量:39
  • 4Nouri-Shirazi J, et al. Dendritic M, Banchereau J, Fay cell based tumor vaecines[J], hnmunol l,ett, 2000, 74 (1): 5-10.
  • 5Harzstark, Air and Small, EJ. Sipuleucel-T for the treatment of prostate cancer[J]. Dings Today (Bare), 2008, 44 (4): 271-278.
  • 6Felvara A, Norm M, Sehr P, et al. Dendritic eell-based tumor vaccine for cervical cancer lh results of a clinical pilot study in 15 individual patients[J]. J Cancer Res Clin Oncol, 2003, 129(9): 521-530.
  • 7Banehereau J, Palucka AK. Dendritic eells as therapeutic vaccines against cancer [J]. Nat Rev lmmunol, 2005, 5(4): 296-306.
  • 8Rosenberg SA, Sherry RM, Morton KE, et al. Tumor progression can occur despite the induction of very high levels of seWtumor antigen-specific CD8^+ T cells in patients with melanoma[J]. J hnmunol, 2005, 175(9): 6169-6176.
  • 9Zitvogel L, Mayordomo Jl, Tjandrawan T, et al. Therapy of murine tu- mors with tmnor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell l-associated cytokines [J]. J Exp Med, 1996, 183(1): 87-97.
  • 10Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity [J]. Nat Med, 1995, 1 (12): 1297-1302.

共引文献121

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部